22 May 2013
Keywords: onyvax, cancer, vaccine, shows, promise, uk, therapeutic
Article | 28 June 2004
UK therapeutic vaccine firm Onyvax has released final Phase II data for Onyvax-P which suggest that it may provide a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 June 2004
5 July 2004
21 May 2013
© 2013 thepharmaletter.com